NASDAQ: CNTXContext Therapeutics Inc Stock Ownership - Who owns Context Therapeutics?
Insider buying vs selling
Have Context Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Martin A. Lehr | Chief Executive Officer | 2025-06-09 | 100,000 | $0.70 | $70.10kBuy |
| Alex C. Levit | Chief Legal Officer Corp. Sec | 2025-06-06 | 20,000 | $0.58 | $11.52kBuy |
| Jennifer Lynn Minaiazary | Chief Financial Officer | 2025-06-06 | 40,010 | $0.64 | $25.49kBuy |
CNTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CNTX insiders and whales buy or sell their stock.
CNTX Shareholders
What type of owners hold Context Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Mpm Bioimpact LLC | 16.01% | 14,705,882 | $21.62M | Institution |
| Avidity Partners Management LP | 9.78% | 8,981,855 | $13.20M | Institution |
| Nextech Invest Ltd | 8.08% | 7,419,355 | $10.91M | Institution |
| Deep Track Capital LP | 8.08% | 7,419,355 | $10.91M | Institution |
| Blue Owl Capital Holdings LP | 8.06% | 7,407,906 | $10.89M | Institution |
| Great Point Partners LLC | 5.10% | 4,683,711 | $6.89M | Institution |
| Franklin Resources Inc | 4.36% | 4,003,380 | $5.88M | Institution |
| Vanguard Group Inc | 3.80% | 3,495,031 | $5.14M | Institution |
| Blackstone Inc | 2.66% | 2,440,330 | $3.59M | Institution |
| Alyeska Investment Group LP | 1.81% | 1,663,355 | $2.45M | Institution |
CNTX vs Biotech Stocks
Context Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.